Because of the controversy and the multiple health and qol-related issues surrounding the use of CA-125 assays, decision analysis techniques with Markov cohort modeling can be useful in quantitatively and transparently evaluating the role of CA-125 in the follow-up management of women with ovarian cancer. Here, MUC16 is linked to ovarian carcinoma.